Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Yang Soon

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
JAMA Network Open|February 13, 2024
Stroke Risk in Survivors of Head and Neck CancerPui Lam Yip, Huili Zheng, Timothy Cheo, et al.
Annals of the Academy of Medicine, Singapore|June 21, 2024
Restaging of rectal cancer with hybrid positron emission tomography magnetic resonance imaging after preoperative chemoradiotherapyJeremy Tey, Jarrod Kh Tan, Ker-Kan Tan, et al.
Radiology and Oncology|December 12, 2022
Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective studyBalamurugan Vellayappan, Dennis Cheong, Salil Singbal, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapyChia Ching Lee, Huili Zheng, Yu Yang Soon, et al.
The Cochrane Database of Systematic Reviews|February 21, 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancerNatalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal AdenocarcinomaJoseph J Zhao, Dominic Wei Ting Yap, Yiong Huak Chan, et al.
Critical Reviews in Oncology/Hematology|October 17, 2021
Central nervous system (CNS) prophylaxis in antiCD20-CHOP treated DLBCL at intermediate to high risk for CNS relapse: A systematic review and meta-analysisGuiyi Ho, Cherie Tan, Sanjay de Mel, et al.
Frontiers in Oncology|January 24, 2022
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral NeuropathyAlisha Joan Leen, Dominic Wei Ting Yap, Chong Boon Teo, et al.
JTO Clinical and Research Reports|September 4, 2023
Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian PerspectiveChee Khoon Lee, Yu Yang Soon, Rosalind L Jeffree, et al.
Cancers|June 22, 2023
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerYiqing Huang, Joseph J Zhao, Yu Yang Soon, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
JAMA Network Open|February 13, 2024
Stroke Risk in Survivors of Head and Neck CancerPui Lam Yip, Huili Zheng, Timothy Cheo, et al.
Annals of the Academy of Medicine, Singapore|June 21, 2024
Restaging of rectal cancer with hybrid positron emission tomography magnetic resonance imaging after preoperative chemoradiotherapyJeremy Tey, Jarrod Kh Tan, Ker-Kan Tan, et al.
Radiology and Oncology|December 12, 2022
Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective studyBalamurugan Vellayappan, Dennis Cheong, Salil Singbal, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapyChia Ching Lee, Huili Zheng, Yu Yang Soon, et al.
The Cochrane Database of Systematic Reviews|February 21, 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancerNatalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal AdenocarcinomaJoseph J Zhao, Dominic Wei Ting Yap, Yiong Huak Chan, et al.
Critical Reviews in Oncology/Hematology|October 17, 2021
Central nervous system (CNS) prophylaxis in antiCD20-CHOP treated DLBCL at intermediate to high risk for CNS relapse: A systematic review and meta-analysisGuiyi Ho, Cherie Tan, Sanjay de Mel, et al.
Frontiers in Oncology|January 24, 2022
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral NeuropathyAlisha Joan Leen, Dominic Wei Ting Yap, Chong Boon Teo, et al.
JTO Clinical and Research Reports|September 4, 2023
Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian PerspectiveChee Khoon Lee, Yu Yang Soon, Rosalind L Jeffree, et al.
Cancers|June 22, 2023
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerYiqing Huang, Joseph J Zhao, Yu Yang Soon, et al.
Pageof 8